Associate, Melbourne | BSc, PhD, MIP Law
Direct +61 3 8662 7313
Catherine specialises in IP matters related to the biotechnology and medical sciences sectors. She practises in the prosecution of Australian and foreign patent applications, drafting of patent applications, providing patentability advice and has assisted in opposition proceedings.
Before joining FPA Patent Attorneys in 2014, Catherine spent six years as a postdoctoral research fellow. Her initial studies at the University of Melbourne encompassed understanding the roles of Wnt and TGF-beta signalling in the development of colorectal cancer.
Following this, Catherine worked as a Senior Research Officer at the Baker IDI Heart and Diabetes Institute where she interrogated the roles of the TGF-beta and BMP pathways in skeletal muscle and cardiovascular related diseases. Through the utilisation of druggable targets and gene therapy, this work led to the development of novel potential therapeutic interventions to treat skeletal muscle wasting and heart disease. During her postdoctoral studies, Catherine also completed an overseas sabbatical at the University of Washington in Seattle where she worked under a world leader in the gene therapy field.
Prior to her postdoctoral career, Catherine completed her PhD which focused on characterising cellular mechanisms that lead to kidney fibrosis. Here, she identified novel roles for PI3K and mTOR signalling pathways in kidney fibrosis. Catherine has published more than 20 peer reviewed articles and reviews in journals including Science Translational Medicine the Journal of Cell Biology, Proceedings of the National Academy of Science of the United States of America (PNAS) and the Journal of Biological Chemistry. These articles can be viewed at the US National Library of Medicine, National Institutes of Health (PubMed).